ChemicalBook >> CAS DataBase List >>Tofacitinib Impurity 44
Tofacitinib Impurity 44
- CAS No.
- 2374700-39-5
- Chemical Name:
- Tofacitinib Impurity 44
- Synonyms
- Tofacitinib Impurity 44;Azilsartan medoxomil impurity320;7H-Pyrrolo[2,3-d]pyrimidin-2-amine, N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-
- CBNumber:
- CB73360221
- Molecular Formula:
- C13H19N5
- Molecular Weight:
- 245.32
- MDL Number:
- MOL File:
- 2374700-39-5.mol
Tofacitinib Impurity 44 Preparation Products And Raw materials
Raw materials
Preparation Products
Tofacitinib Impurity 44 Suppliers
Global( 12)Suppliers
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
Standardpharm Co. Ltd. | 86-714-3992388 | overseasales1@yongstandards.com | United States | 14332 | 58 |
ANHUI WITOP BIOTECH CO., LTD | +8615255079626 | eric@witopchemical.com | China | 23541 | 58 |
Beijing Comparison Pharmaceutical Technology Co., Ltd | 010-010-52878169 15801002657 | sales@bjcomparison.com | China | 4990 | 58 |
Shijiazhuang yaoBo Pharmaceutical Co., Ltd. | 15633056635 | 2880679888@qq.com | China | 2916 | 58 |
Jinan blalong chemical co. LTD | 2710913286@.com | 1513643261@qq.com | China | 14246 | 58 |
Shenzhen ruikai de biotechnology co., ltd. | 0755-61348847 17820674378 | 2682116078@qq.com | China | 7843 | 58 |
Cato Research Chemicals Inc. | 020-81215950 4000-868-328 | customer@uwalab.com | United States | 10404 | 58 |
Wuxi Helen Biotechnology Co., Ltd., | 0510-85629785 18013409632 | sales@reading-chemicals.com | China | 14081 | 58 |
Foshan Treasure Biotechnology Co., Ltd | 0757-85921206 18520245316 | 2329783215@qq.com | China | 12661 | 58 |
Hunan Zengda Biological Technology Co., LTD | 18711085600 | 1652923704@qq.com | China | 4582 | 58 |
2374700-39-5(Tofacitinib Impurity 44)Related Search:
N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Tofacitinib Impurity
Tofacitinib Impurity 36
6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine
7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-7-[(4-Met hylphenyl)sulfonyl]-
1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, ethyl ester, (3R,4R)-
3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide
3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile
N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Tofacitinib Impurity
butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate
3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI)
N-(2,6-dimethylphenyl)-2-((2,6-dimethylphenyl)amino)acetamide
(3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine
1-BENZYL-N,4-DIMETHYLPIPERIDIN-3-AMINE DIHYDROCHLORIDE
1of4
Tofacitinib Impurity 44
Azilsartan medoxomil impurity320
7H-Pyrrolo[2,3-d]pyrimidin-2-amine, N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-
2374700-39-5